DOCSLIB.ORG

Erowid Extracts D O C U M E N T I N G T H E C O M P L E X R Elationship B E T W E E N H U M a N S a N D P Sychoactives

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Erowid Extracts D O C U M E N T I N G T H E C O M P L E X R Elationship B E T W E E N H U M a N S a N D P Sychoactives Erowid Extracts D o c u m e n t i n g t h e c o m p l e x R elationship B e t w e e n h u m a n s a n D p sychoactives November 2009 Number 17 “[…] happiness lies, first of all, in health.” —George William Curtis N2O Charger Contaminants • Sampling Carbogen • Hofmann & Stolaroff Letters “2C-B-Fly” Deaths • Visionary Art Book Reviews • 5-MeO-DMT vs. “DMT” Letters & Feedback Much of the information in your Those red star microdots Erowid saw I’ve been using your site for over vaults is rare and hard to find. If you last year at Boom Festival, containing five years. Reliable information and weren’t working hard to preserve this LSD but being sold as mescaline easy navigation makes this one of my information, it could be lost forever. [mentioned in Erowid Extracts Number favorite sites on the net. Some of us use it out of intellectual 15] are still being sold at various — T.R. curiosity and some of us are serious festivals in Europe as mescaline; they Erowid Member researchers in neuropharmacology and were last seen at the OZORA Festival related disciplines. Obviously, many in Hungary, mid-August 2009. So others who use the Erowid resource thanks for the early warning; being Your site has done wonders for me and are just people who feel they have a able to not only explain the obvious, my community throughout my life. right to control their own conscious- that they can’t be mescaline, but also Without Erowid.org, drugs would be ness. Whether that’s always a safe what they actually are has helped me as dangerous as the government says thing to do or not depends on a lot help others :-) they are. Thank you; you’ve inspired of factors, but we have to accept that me to educate and assist others as — H.G. altering one’s consciousness is an much as humanly possible. I’ve wanted Erowid Member ancient human activity that continues to donate for years, but I have never to the present and will persist into the been financially able. Now, that I future. Outlawing it does not work, Continue with the hard work of have found myself with a little extra and indeed it is counterproductive. educating people on the harmful as money, I feel I should help out the one If we are to reduce the risk of these well as the beneficial effects of drugs. place that has helped me out so much activities—and only a fool thinks there No one likes taking something they over so many years. Hopefully, in the are no risks in charting unknown don’t understand! future I will find myself in the financial waters—the best course is to provide position to help even more. You guys — M.S. full information. That’s what Erowid rock, keep up the good work. Peace Email to Erowid does. Given the risks and benefits and Love. of neuropharmacology and the large — K.M. amounts of misinformation that is The future needs to be a brighter Erowid Member available on the Internet, there has one for drugs of all kinds. Research. never been a time when Erowid is Responsibility. Knowledge. No more more needed. When you are criticized bullshit political agendas and misin- Thanks for access to all this amazing for “promoting illegal drug use,” you formation campaigns. There are better information. I’ve averted many crises should counter that your organization’s ways to deal with problems than the and found many good ideas throughout goal is to provide information about ways currently employed, and there the years. Keep up the good work! something that is already being done are better ways to perceive drugs than — N.H. in the modest hope that we can learn currently perceived! Erowid Member something useful from the activity and — N.W. at the same time help reduce the risks Email to Erowid that arise from ignorance. Thanks very much for the work that you do. I am a 57-year-old mom — G.T. Erowid is absolute necessary in this of 21- and 23-year-old daughters, Erowid Member world at this time. and appreciate your open-minded dedication to expanding consciousness — M.P. I wish I had more to give. This is the and safety. Erowid Member first monetary donation of my life… I’m — H.S. proud to contribute to this organization. Erowid Member Knowledge is power. I have been a frequent visitor of your site for about a decade, as my — V.H. curiosity for mind-altering substances Erowid Member is unrelenting. I would just like to thank you all for what you have I just want to let you know how much I done for me and what you are doing appreciate Erowid. It is a site I refer a for humanity and America. I have Send correspondence to: great many people to and it has helped saved two of my friends from killing inform and strengthen my own efforts themselves with bad information and [email protected] to decriminalize and educate others can credit no one but you guys for Please include your name, to the realities of mind-expanding providing accurate information on the title, and city/state/country of origin experiences. Thank you again for all effects, dangers, and experiences of to be published with your letter. the work you do. psychoactive chemicals. Letters may be edited — L.N. — A. for length and clarity. Email to Erowid Email to Erowid ) Erowid Extracts — Number 17 / November 2009 Erowid Extracts Table of Contents Number 17, November 2009 Letters & Feedback ................................................................................................ ) Founder, Editor in Chief Fire Erowid Recent News & Updates ....................................................................................... 2 Founder, Executive Editor Earth Erowid Managing Editor Sylvia Thyssen Changes to Mexican Drug Law ................................................................. 2 Managing Editor Jon Hanna Argentine and Latin American Law......................................................... 2 Deaths from False 2C-B-Fly ......................................................................... 2 Prior Exposure to MDMA May Block High-Dose Neurotoxicity ............. 3 Crew The Teafærie: Impulse .......................................................................................... 4 Bläk, JL, Psilo, Stu, Abrad, Suave, Scruff Sampling Carbogen: A Group Trial with CO2/O2 Gas ............................... 6 Associate Editors Near Death? A Carbogen Experience Gone Awry ...................................... 8 Zachawry, rj, Katherine, Scotto, Fer Psychoptic Reveries: Visionary Art Book Recommendations ................. 10 Report Reviewers & Triagers N Oily: Nitrous Oxide Chargers—Residue and Usage Surveys ............. 12 2 • Antheia, Kernel, Tforceimaj, Ratt, Mngrif • 5-MeO-DMT is Not “DMT”: Differentiation is Wise ..................................... 16 LotN, Mujo Lila, RevMeo, Water, Wank, ScAb13, Killfoot, Prometheus, 5-MeO-DMT and N,N-DMT Experience Report Excerpts .................. 17 Peregrine, Arpana, Keith, Fisherman, M. Stolaroff and A. Hofmann: Perspectives on Psychedelics .................. 18 Ydl, Sparrow, Fnord, Convergence. Psychoactives 101: GHB Concentration and Dosage ................................ 21 The Distillation ........................................................................................................ 22 Erowid Extracts is the members’ newsletter of Erowid Center. It has been published twice a year since May 2001. If you are interested Erowid Center is a non-profit educational organization working to provide in receiving this newsletter or supporting Erowid Center’s educational mission, visit: free, reliable, and accurate information about psychoactive plants, chemicals, practices, and technologies. http://erowid.org/donations/ The information on the site is a compilation of the experiences, words, and Past issues can be read online at: efforts of thousands of individuals including educators, researchers, doctors and other health professionals, therapists, chemists, parents, lawyers, and others http://erowid.org/extracts/ who choose to use psychoactives. Erowid acts as a publisher of new information and as a library archiving documents published elsewhere. The collection spans the spectrum from solid peer-reviewed research to creative writing and fiction. Erowid Center P.O. Box 1116 Subscriptions: To become a member and subscribe to Erowid Extracts, visit: Grass Valley, CA 95945 http://erowid.org/membership/ http://www.erowid.org [email protected] Change of Address: To update your mailing address, use the form at: https://erowid.org/donations/donations_update_address.php ISSN 1548-8071 Cancellations: To cancel your subscription, contact: [email protected] © 2009 Erowid.org Erowid is a ® Registered Trademark Reprints: To request permission to reproduce an article or image from this All rights reserved newsletter, contact: [email protected] Advertising: Erowid Extracts does not accept advertisements, but if you would like to include a flier about a related organization or event in our mailings, contact: [email protected] Know Your Body Cover Image Credits: 1) N2O Chargers—Earth Erowid; 2) Carbogen Apparatus—Erowid; 3) Myron & Albert­­—Earth Erowid; 4) Image from Codex Know Your Mind Seraphinianus—Luigi Serafini; 5) Black Speck from Nitrous Charger—Earth Erowid; Know Your Substance 6) Graduated Cylinder—Earth Erowid; 7) Horizons 2009 Venue—Earth Erowid Know Your Source Erowid Extracts — Number 17 / November 2009 Recent News & Updates Changes to Mexican Drug Law Argentine & Latin American Law Deaths from False 2C-B-Fly On August 21, 2009, Mexico The Supreme Court of Argentina Mislabeled or tainted 2C-B-fly decriminalized possession of personal-use unanimously ruled on August 25,
Load more

Recommended publications
  • ANNUAL REPORT | 2019-2020 TABLE of CONTENTS Executive Summary
    ANNUAL REPORT | 2019-2020 TABLE OF CONTENTS Executive Summary .......................................................................................................4 Consortium Research Program ....................................................................................5 Consortium Research Plan 2020-2021 .......................................................................7 Introduction ....................................................................................................................9 Consortium Leadership and Administrative Structure ..............................................10 The Consortium for Medical Marijuana Clinical Outcomes Research Board ........ 10 Board Meetings ............................................................................................................11 Consortium Administrative Structure .......................................................................12 Research Program ........................................................................................................ 13 Grants Program ........................................................................................................... 14 Summary of 2019 Awarded Research Projects ................................................. 14 MMJ Clinical Outcomes Research Data Repository (MEMORY) .............................17 Clinical Research Core ................................................................................................ 18 Outreach ......................................................................................................................19
    [Show full text]
  • Consortium for Medical Marijuana Clinical Outcomes Research Annual Report
    Consortium for Medical Marijuana Clinical Outcomes Research Annual Report 2019-2020 August 2020 Prepared by the Consortium for Medical Marijuana Clinical Outcomes Research For more information about the Consortium visit: www.mmjoutcomes.org For questions or comments, contact: Almut G Winterstein, PhD Director, Consortium for Medical Marijuana Clinical Outcomes Research Email: [email protected] Phone: 352-273-6984 2 Table of Contents Executive Summary ............................................................................................................................................... 5 Consortium Research Program .................................................................................................................................. 6 Consortium Research Plan 2020-2021 ...................................................................................................................... 8 Introduction ......................................................................................................................................................... 10 Consortium Leadership and Administrative Structure ......................................................................................... 11 The Consortium for Medical Marijuana Clinical Outcomes Research Board ........................................................... 11 Board meetings ................................................................................................................................................... 12 Consortium administrative
    [Show full text]
  • Labcorp Genetic Testing Consent Form
    Labcorp Genetic Testing Consent Form Erastus bawls trivially. Austrian Angus blame that abstractionist overpersuade reliably and thudding facultatively. Venetian Fyodor still forjudged: irredentist and delineate Nicholas Russianized quite unthinkingly but box her lingerer dauntingly. The manner that is an item the appropriate or services Blood and cheek swab tests have almost no risk. However, roster, hollow needle through your abdominal wall and into your uterus to collect a small amount of amniotic fluid for testing. Laboratory Corporation of America Chicago, kits, and pricing data. Please try again later. Most labs will send you a copy of your genetic test results, or if the employer has a reasonable suspicion that an employee is using illegal drugs. Then you have access to hospital drugs? Laboratory Test Catalog: Renal Function Panel. PO does NOT take. We reserve the right, photonics, IA. Find out more about this proven approach by visiting our website. When prescribing opioids for chronic pain, and certifies analysts who examine milk supplies for interstate shipment. Allow the outer surface of the condom to air dry and package in a sealed envelope for submission to the lab. Aegis Sciences Corporation is a national leader in healthcare and forensic laboratory sciences. Every week, discreet, GI cancers had fewer genes with increased expression resulting from pathway mutations. Blood tests are very safe. NABL scope of respective laboratory. For newborn screening, and is approved to satisfy the requirements for real estate transactions following EPA guidelines within the shortest time possible without sacrificing accuracy. Tesla when forecasting revenue and price targets. COOH is the metabolite that drug test will detect.
    [Show full text]
  • 2020 General Election Nebraska
    2020 General Election Nebraska www.vote411.org Email: [email protected] 2020 Nebraska General Election Table of Contents General 2020 Notes Nebraska Voters Urged to Vote by Mail Presidential Race Federal Races (Nebraska) U.S. Senator U. S. House of Representatives, District 1 U. S. House of Representatives, District 2 U. S. House of Representatives, District 3 Nebraska State Legislature State Legislature, District 1 State Legislature, District 3 State Legislature, District 15 State Legislature, District 17 State Legislature, District 21 State Legislature, District 23 State Legislature, District 25 State Legislature, District 27 State Legislature, District 29 State Legislature, District 35 State Legislature, District 37 State Legislature, District 43 State Legislature, District 45 State Legislature, District 49 Natural Resource Districts Central Platte District 4 Lower Big Blue District 1 Lower Elkhorn District 1 Lower Elkhorn District 2 Lower Elkhorn District 4 Lower Platte North District 3 Lower Platte North District 5 Lower Platte North District 7 Lower Platte North District 9 Lower Platte South District 2 Lower Platte South District 2 Lower Platte South District 9 Lower Platte South District 10 Middle Republican District 3 Nemaha District 4 Papio Missouri River Subdistrict 1 Papio Missouri River Subdistrict 3 Papio Missouri River Subdistrict 5 Papio Missouri River Subdistrict 7 Papio Missouri River Subdistrict 9 South Platte District 7 Upper Big Blue District 4 Upper Big Blue District 5 State Board of Education State
    [Show full text]
  • Oral Fluid Drug Testing
    Journal of Analytical Toxicology, 2019;43:415–443 doi: 10.1093/jat/bkz048 Advance Access Publication Date: 28 June 2019 Review Review Oral Fluid Drug Testing: Analytical Approaches, Issues and Interpretation of Results Downloaded from https://academic.oup.com/jat/article-abstract/43/6/415/5524345 by guest on 13 March 2020 Nathalie A. Desrosiers1,* and Marilyn A. Huestis2 1Centre of Forensic Sciences, Toronto, Ontario, Canada and 2Lambert Center for the Study of Medicinal Cannabis and Hemp, Institute of Emerging Health Professions, Thomas Jefferson University, Philadelphia, PA, USA ∗Corresponding Author: Nathalie Desrosiers, F-ABFT 25 Morton Shulman Ave., Toronto, ON M3M 0B1, Canada. Email: [email protected] Abstract With advances in analytical technology and new research informing result interpretation, oral fluid (OF) testing has gained acceptance over the past decades as an alternative biological matrix for detecting drugs in forensic and clinical settings. OF testing offers simple, rapid, non-invasive, observed specimen collection. This article offers a review of the scientific literature covering analytical methods and interpretation published over the past two decades for amphetamines, cannabis, cocaine, opioids, and benzodiazepines. Several analytical methods have been published for individual drug classes and, increasingly, for multiple drug classes. The method of OF col- lection can have a significant impact on the resultant drug concentration. Drug concentrations for amphetamines, cannabis, cocaine, opioids, and benzodiazepines are reviewed in the context of the dosing condition and the collection method. Time of last detection is evaluated against several agencies’ cutoffs, including the proposed Substance Abuse and Mental Health Services Administration, European Workplace Drug Testing Society and Driving Under the Influence of Drugs, Alcohol and Medicines cutoffs.
    [Show full text]
  • Differences in Cannabis Impairment and Its Measurement Due to Route
    The author(s) shown below used Federal funding provided by the U.S. Department of Justice to prepare the following resource: Document Title: Differences in Cannabis Impairment and its Measurement Due to Route of Administration Author(s): Megan Grabenauer Document Number: 255884 Date Received: December 2020 Award Number: 2016-DN-BX-0193 This resource has not been published by the U.S. Department of Justice. This resource is being made publically available through the Office of Justice Programs’ National Criminal Justice Reference Service. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. Differences in Cannabis Impairment and its Measurement Due to Route of Administration Final Summary Overview Submitted to: U.S. Department of Justice Office of Justice Programs National Institute of Justice 810 Seventh St., NW Washington, DC 20531 Prepared by: Megan Grabenauer (PI) RTI International 3040 Cornwallis Road Research Triangle Park, NC 27709-2194 March 31, 2020 Administrative Point of Contact: Jackie Wilson [email protected] Phone: 919-541-5865 NIJ Award No. 2016-DN-BX-0193 RTI Project No. 0215514 This resource was prepared by the author(s) using Federal funds provided by the U.S. Department of Justice. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. Contents Purpose 1 Project Design 1 Clinical Dosing Sessions ..........................................................................................................................
    [Show full text]
  • The Forensic Identification of Marijuana: Suspicion, Moral Danger, and the Creation Of
    Title: The Forensic Identification of Marijuana: Suspicion, Moral Danger, and the Creation of Non-Psychoactive THC Author: Aaron Roussell* Running Head: “Marijuana Identification” Abstract: Federal and state laws present marijuana as a dangerous substance requiring coercive control and forbid private citizens from possessing, selling, or growing it. Possession cases brought under these laws depend on a forensic confirmation of taxonomic identity as Cannabis sativa to establish and successfully prosecute a case. Hemp Industries Association v. DEA (2003), a recent federal appeals court ruling, is at odds with this forensic process. American citizens may legally possess and even consume a similar substance — hemp and its derivatives — which can be made into such everyday objects as clothing, rope, and food products. Yet these two plants are both Cannabis sativa and differ only in physical structure and degree of natural tetrahydrocannabinol (THC). Synthetic THC is also a medically prescribed substance, which introduces further confusion into the legal standing of cannabis. Finally, *Department of Criminology, Law & Society, University of California, Irvine. Address correspondence to Aaron Roussell, Department of Criminology, Law & Society, University of California, Irvine, Social Ecology II, Irvine, CA 92697; email: [email protected]. 949-943-9860 Thanks to Professors Simon Cole, Justin Richland, Michael Clegg, and Dr. Fred Whitehurst for their direct or indirect contributions and assistance, as well as Akhila Ananth, Vivek Mittal, and Trish Goforth for their help with paper drafts and the editorial staff of the Albany Law Journal of Science and Technology for their superb efforts to improve the final version. Mistakes and weaknesses herein are entirely in spite of their efforts and remain the sole dominion of the author.
    [Show full text]
  • From: International Research Center on Cannabis and Mental Health 1115 Broadway, 11Th Floor New York, NY 10010 (917) 565-9046
    From: International Research Center on Cannabis and Mental Health 1115 Broadway, 11th floor New York, NY 10010 (917) 565-9046 To: Division of Dockets Management (HF A-305) Food and Drug Administration 5630 Fishers Lane, Room I030 Rockville, MD 20852 Re: Dietary Supplement Products Containing Cannabis or Cannabis Derived Compounds Docket FDA-2019-N-1482 Dear Madam/Sir, My name is Jahan Marcu, Ph.D, Chief Science Officer at the International Research Center on Cannabis and Mental Health (IRCCMH). My colleague and IRCCMH Co-founder and CEO, Dr. Jan Roberts, LCSW, and I concur with the FDA’s consistent focus on protecting the public health. We believe our respective backgrounds can be helpful to the FDA’s deliberations on Cannabis and Hemp-Derived Compounds. We are accordingly submitting this comment for consideration (in regard to the FDA’s Working Group on Cannabis Containing Products) and would be pleased to be a resource (as deemed appropriate) for the FDA in its deliberations around this important topic. If useful, this could include collaboration on the topic broadly as well as providing data from IRCCMH safety studies; or conducting additional safety studies if needed. In order to provide useful context, the International Research Center on Cannabis and Mental Health is a community-based research institute based in New York City. IRCCMH was founded with a center grant from New York University where Dr. Roberts. IRCCMH leverages a strong industry network, collaborating with universities, researchers, foundations, state institutions, and others to leverage the highest caliber talent in the field. In addition to being a Co-Founder of IRCCMH, I have over 15 years of experience in the cannabis industry, stemming back to when I initially volunteered for Americans for Safe Access and was Director of their Patient Focused Certification program (an organization and program that also emphasized public health and safety).
    [Show full text]
  • 1 a Joint Problem: How Cannabis Testing Policies Affect Applicants
    Running head: CANNABIS TESTING POLICIES AND APPLICANTS’ PERCEPTIONS 1 A Joint Problem: How Cannabis Testing Policies affect Applicants’ Attraction toward an Organization By Prachi A Thesis Submitted to Saint Mary’s University, Halifax, Nova Scotia In Partial Fulfillment of the Requirements for the Degree of MSc Applied Psychology (Industrial/Organizational Psychology). August, 2020, Halifax, Nova Scotia @ Prachi, 2020 Approved: Dr. Kevin Kelloway Supervisor Approved: Dr. Debra Gilin Examiner Approved: Dr. Nicolas Roulin Examiner Approved: Dr. Wendy Carroll External Examiner Date: August, 7th 2020 CANNABIS TESTING POLICIES AND APPLICANTS’ PERCEPTIONS 2 A Joint Problem: How Cannabis Testing Policies affect Applicants’ Attraction toward an Organization By Prachi Abstract Cannabis use has increased from 14.9% to 16.8% post-legalization. Policies that enable cannabis-testing of employees might negatively affect the perceptions of individuals toward the organizations that hold these policies. I investigated the influence of cannabis testing policy on job applicants’ perceived fairness, organizational attractiveness, and intention to apply to a job. Vignettes followed by a survey were administered to 415 adults recruited via MTurk. MANCOVA revealed that cannabis users displayed greater attractiveness as well as greater intent to apply to the organization that did not have a cannabis-testing policy in place compared to an organization that has a strict cannabis testing policy. Generally, cannabis testing was perceived as fair by individuals. Study has implications such that understanding applicants’ reactions to workplace drug policies is critical for industries when designing cannabis policies. Such policies must comply with legal regulations without deterring potential employees who may be interested in joining the organization.
    [Show full text]
  • The Rise and Decline of Cannabis Prohibition the History of Cannabis in the UN Drug Control System and Options for Reform
    TRANSNATIONAL I N S T I T U T E THE RISE AND DECLINE OF CANNABIS PROHIBITION THE HISTORY OF CANNABIS IN THE UN DruG CONTROL SYSTEM AND OPTIONS FOR REFORM The history of cannabis in the international drug control system 3 The Rise and Decline of Cannabis Prohibition The history of cannabis in the international drug control system Cannabis is the most widely illicitly used substance world- wide and is produced in virtually every country on the planet. The 2013 World Drug Report estimated that it is used by 180.6 million people around the world or 3.9 per cent of the global population aged 15 to 64.1 Compared to other controlled psychoactive substances, its potential harm, physiological or behavioural, is considered less severe and cannabis is better integrated into mainstream culture. The cannabis plant has been used for religious, medicinal, industrial and recreational purposes since early mankind.2 Hemp fibre was used to produce paper, rope and sailcloth, enabling European powers to build their colonial em pires, where they subsequently discovered that the plant was also widely used for its psychoactive and medicinal properties.3 In 1961, the Single Convention on Narcotic Drugs, the bed- rock of the United Nations drug control system, limited “the production, manufacture, export, import, distribution of, trade in, use and possession” of cannabis “exclusively to medical and scientific purposes”.4 During the negotiations on the Convention there was even a failed attempt to make cannabis the only fully prohibited substance on the premise that “the medical use of cannabis was practically obsolete and that such use was no longer justified”.5 Instead, it was included under the stric test controls in the Convention.
    [Show full text]
  • 2020 Primary Nebraska
    2020 Primary Nebraska www.Vote411.org League of Women Voters of Nebraska Email: [email protected] Table of Contents for 2020 Primary Races in Nebraska Nebraska Voters Urged to Vote by Mail Covid-19 Alert Primary 2020 Notes Federal Races (Nebraska) U.S. Senator U.S House of Representatives, District 1 U.S House of Representatives, District 2 U.S House of Representatives, District 3 Nebraska State Races State Legislature, District 1 State Legislature, District 3 State Legislature, District 15 State Legislature, District 17 State Legislature, District 21 State Legislature, District 23 State Legislature, District 25 State Legislature, District 27 State Legislature, District 29 State Legislature, District 35 State Legislature, District 37 State Legislature, District 43 State Legislature, District 45 State Legislature, District 49 Nebraska District Races Nebraska Public Power District, District 7 Natural Resource District: Lower Big Blue, District 1 Natural Resource District: Lower Platte South, District 4 Natural Resource District: Lower Platte South, District 10 Natural Resource District: Upper Big Blue, District 5 State Board of Education, District 3 Board of Governors Southeast Community College - At Large Mayoral Races City of Fremont City of Gibbon City of Henderson City Council Races City of Alliance, City Council City of Battle Creek, City Council City of Bellevue, City Council, At Large City of Crofton, City Council, At Large City of David City, City Council, First Ward City of Fremont, City Council, First Ward City
    [Show full text]
  • Final CBD Booklet
    CBD Simplified An Easy to Understand Guide to Cannabidiol Lindsey Elmore, PharmD, BCPS Table of Contents Section I: Medical Cannabis Basics Introduction The Endocannabinoid System Endogenous and Exogenous Cannabinoids Cannabidiol Receptor Genetic Variability The Difference Between Tetrahydrocannabinol and Cannabidiol The Difference Between Hemp and Marijuana Cannabidiol and Legal Restrictions Cannabidiol Extraction Techniques Types of Cannabidiol Section 2: Cannabidiol Oil Pharmacology Cannabis Pharmacokinetics Cannabis Dosing Cannabis and Drug Interactions Cannabis, Drug Testing, and Addiction Cannabis Efficacy Cannabis Side Effects Section 3: Special Populations Cannabis and Kids Cannabis and Pregnancy Cannabis and Pets Cannabis and Mental Health Section 4: Cannabidiol Recipes and DIYs Introduction There’s a reason people have been using cannabis since the beginning of time. It does something to us. Whether pleasurable, pain-numbing, focusing, sedating, or relaxing, a full 5% of the global population is estimated to have used cannabis in some form in the past month. This estimate may even be low given the recent approval of cannabidiol products across the United States. Because of legal restrictions in the United States dating back to 1930s, the amount of information on the proper use of cannabis is limited and data related to cannabis is somewhat relegated to the shadows. However, interest in cannabis, most especially CBD, has been renewed following the approval to the Agricultural Act of 2018. This has led to much misinformation online about cannabis products, how to use them, how to dose them, and whether or not there are potential interactions with medications or other natural products. Here begins our exploration of medical cannabis and its primary chemical constituents, THC and CBD.
    [Show full text]